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Background & Aim: Visceral leishmaniasis (VL) or kala-azar is a protozoan disease caused by 
some species of Leishmania donovani complex. Mediterranean type of the disease is endemic in 
various parts of Iran. A cross-sectional study was designed to determine the seroprevalence of VL 
among asymptomatic adult population in Meshkin-Shahr area from the Northwest of Iran as an 
endemic focus of VL. 
Methods & Materials: Altogether, 180 blood samples were collected from asymptomatic adults’ 
population throughout 2015. Before sampling, a questionnaire was separately completed for each 
individual. All the collected blood samples were examined by direct agglutination test (DAT) after 
plasma separation. Anti-Leishmania infantum antibodies at titers 1:100 to 1:1600 was considered as 
L. infantum infection, while the cut-off titer of ≥ 1:3200 with specific signs and symptoms was 
considered as VL. 
Results: From 180 collected plasma samples, nine (5%) of them showed anti-Leishmania 
antibodies at titers 1:400 and higher. Distribution of anti-Leishmania antibodies titers was 1:400 
(n = 2), 1:800 (n = 4), and 1:1600 (n = 3). All of the seropositive cases were observed among 
females. All the seropositive individuals had not a history of kala-azar. The highest seropositivity 
rate was observed among the age group of 13-23 years old. No changes in titers of anti-
Leishmania antibodies observed after collected the seropositive blood samples again and tested 
by DAT with 1-month interval. 
Conclusion: Visceral Leishmania infection is relatively high among adult people reside in Meshkin-
Shahr area without any clinical manifestations. Asymptomatic VL infection is very important in 
immunocompromized individuals such as HIV-positive cases; these patients are at risk to 
manifesting clinical signs and symptoms of VL. Therefore continuing serological surveillance for 
detection of visceral Leishmania infection should be recommended in the endemic foci of VL. 
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Introduction 
Visceral leishmaniasis (VL) is a protozoan 
disease can be produced by Leishmania 
donovani complex such as Leishmania infantum 
in the Middle East and Mediterranean area (1). 
The disease generally transmitted by the bite of 
the female sand fly. Canines are main reservoir 
hosts of VL in Mediterranean region (1). VL is 
the most severe form of leishmaniasis in the 
world. The annual occurrence of human VL 
worldwide is estimated 500,000 and about 
59,000 deaths (2) and approximately 100-300 in 
Iran (3). Since the last decade, the incidence rate 
of Mediterranean type of VL has increased, 
mostly because of Leishmania-HIV coinfection 
(4). In humans, L. infantum causes several 
clinical signs and symptoms, from asymptomatic 
or oligosymptomatic infection to acute or 
chronic disease (5). The clinical signs and 
symptoms of the disease are as follows: fever, 
hepatosplenomegaly, substantial weight loss, 
progressive anemia, and death (6). VL has a 
high mortality rate in untreated patients, 
malnourished cases and in cases of VL/HIV 
coinfection (7). Diagnosis of VL is done by 
parasitological methods (demonstration of 
amastigotes in biopsies of aspirates or by culture 
of parasite), serological tests, and molecular 
methods. Parasitological method is painful, and 
molecular methods need advanced lab 
equipment but serological tests, particularly 
direct agglutination test (DAT), do not require 
advanced lab equipment in comparison with 
other methods. Hence, they are completely 
appropriate for use under field conditions (8). In 
this study, DAT was used to detect of 
seropositive samples because it is simple, valid, 
and cost-effective test (sensitivity and specificity 
of the DAT were calculated 92-100% and  
72-100%, respectively) (2, 3, 9). The presence of 
the first case of VL in Iran was reported from 
the Mazandaran Province in 1949 (10). Since 
1980, annually more than 100 human cases have 
been diagnosed from the Northwest of Iran, 
mostly, from Meshkin-Shahr areas among 
children under 12-year-old (3). It shows that VL 
has been endemic in this area for a long time 
(11). This study was conducted to determine the 
seroprevalence of VL among adults’ people in 
above-studied areas among the adult population. 
It was carried out from February 2015 to 
January 2016 for making aware of present status 
and endemicity of VL in this area and selection 
and implementation of optimal control program 
if necessary. 
Methods 
Meshkin-Shahr District is located in Ardabil 
Province, Northwest of Iran (Figure 1). Sabalan, 
one of the highest and famous mountains of Iran 
is located near the city. The city of Meshkin-
Shahr is situated at an altitude of 1490 m above 
the sea and the weather of it is moderate 
mountainous. It covers an area of approximately 
1530 km
2
 including 323 villages and its 
population is estimated to be 169,967 among 
which 42% was settled in urban areas and 58% 
in rural areas (12). 
 
 
Figure 1. Geographical situation of Meshkin-Shahr District in Ardabil Province, Northwest of Iran 
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This descriptive cross-sectional study was 
conducted during February 2015 to January 
2016 for 1 year. A simple randomized sampling 
method was used for the sample collection. A 
questionnaire was completed by each subject, 
recording sociodemographic characteristics (age 
groups, gender, location, occupation, history of 
VL, clinical symptoms, and directly contact with 
domestic dogs). Blood samples were taken from 
180 adults (≥ 13-year-old) subjects randomly. 
Subjects were consisting of 33 (18.3%) male and 
147 (81.7%) female, samples were collected in 
ethylenediaminetetraacetic acid-coated tubes and 
processed them 4-10 hours after collection, then 
samples centrifuged at 2000 ×g for 5 minutes 
and then plasma was collected in individual 
micro tubes in order to DAT examination and 
were stored at −20° C until tested. The  
L. infantum antigens for this study were made in 
the Parasitology Unit of the School of Public 
Health in the Tehran University of Medical 
Sciences. The first step of preparing DAT 
antigen was the production of promastigotes 
mass of Iranian strain of L. infantum 
[MCAN/IR/07/Moheb-gh. (GenBank Accession 
No. FJ555210)] in RPMI1640 medium (Biosera, 
South America) in addition 10% fetal bovine 
serum (Biosera, South America), following 
trypsinization of the parasites, staining with 
Coommassie brilliant blue R-250 (Sigma, USA) 
and fixing with formaldehyde 1.2% (9, 13, 14). 
All plasma samples were tested by DAT. The 
procedure described by Mohebali et al. followed 
for titration of Leishmania-specific antibodies 
(9). Overall, for screening of samples, three 
dilutions of 1:800, 1:1600 and 1:3200 were 
made and tested. The samples that were positive 
with titer 1:400 and higher were diluted up to 
1:102400 in a V-shaped microtiter plate. Plasma  
diluent (physiological saline) contains 0.78%  
b-mercaptoethanol and 0.2% gelatin. Then,  
50 µl of antigen suspension was added to each 
well. After 1 minute of gentle shaking on a ﬂat 
surface, the plate was covered and stayed near 
wet cotton as a wet room in temperature of  
21-25 °C, and then results were read after 18-24 
hours. The highest dilution, which is 
agglutination, was still recognizable in 
comparison with positive and negative controls 
titer was defined as the titer of the sample. 
Compact blue dots with specified margin were 
defined as negative subjects, and large diffuse 
blue mass was defined as positive subjects. 
Antigen control well (antigen and diluent plasma 
only) and negative and positive controls were 
used for comparison in each plate daily. Titers of 
≥ 1:3200 were considered as seropositive  
(9, 15-19) the cutoff was based on the previous 
studies (15, 18, 20). The finding was analyzed 
by SPSS software (version 19, SPSS Inc., 
Chicago, IL, USA), with a P < 0.05 considered 
as statistically significant. Chi-squared and 
Fisher exact tests were followed to comparison 
of prevalence values relative to the 
characteristics of subjects.  
Results 
Of the 180 plasma samples collected from 
adults’ subjects of Meshkin-Shahr district, 9 
cases (5%) showed anti-Leishmania antibodies 
in at titers 1:400, 1:800, 1:1600. Two cases 
presented a titer of 1:400, four had a titer of 
1:800, and three cases had a titer of 1:1600 
(Table 1).  
 
Table 1. Results of DAT s on 180 plasma samples 
collected from adult population from Meshkin-Shahr 
District, in 2015 
Number of  
examined 
Antibody titer 
Total 
1:400 1:800 1:1600 
180 No No No No 
2 (1.1%) 4 (2.2%) 3 (1.7%) 9 (5%) 
DAT: Direct agglutination tests 
 
The frequency of anti-Leishmania antibody 
titers with DAT according to the age groups can 
be seen in figure 2. In this study, anti-
Leishmania antibodies were not detected in titer 
≥ 1:3200, any clinical symptoms observed in all 
seropositive subjects, and nobody had the 
previous history of the disease or remembered it 
in the past. 
The study populations were consisting of 33 
(18.3%) male and 147 (81.7%) female, with age 
ranging from 13 to 79 years. Most of the cases 
were aged 23-33 years. Age, gender and the rate 
of antibody titers distribution of seropositive 
subjects can be seen in table 2.  
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Figure 2. Results of direct agglutination tests from 
180 collected plasma samples by age group 
 
All of the seropositive cases were observed 
in females group. The highest proportion of 
positive subjects was observed in 13-23 years 
group. There was no significant difference 
between the rate of seropositivity and other 
sociodemographic characteristics (age groups, 
gender, location, occupation, history of VL, 
clinical symptoms, and contact with animals)  
(P > 0.05). The occupation of 8 seropositive 
subjects was household and one was a student.  
In the present study after a month, five out of 
nine seropositive subjects were tested again and 
followed up for anti-L. infantum antibodies, but 
none differences observed between in recent and 
previous tests. Due to any apparent clinical 
symptoms has been observed in seropositive 
subjects, we resulted that subjects just contact 
with the parasite but they do not get any active 
disease, therefore, the present investigation 
found asymptomatic subjects in the study region. 
Discussion  
This study is the first seroepidemiological 
survey of Leishmania infection among adults in 
one of VL-endemic area in the Northwest of 
Iran, Meshkin-Shahr District. This study aimed 
to assess the rate Leishmania infection in adults; 
therefore, 180 samples have been prepared from 
Meshkin-Shahr area, in Ardabil province.  
Findings of this study revealed that 5% of 
healthy cases in Meshkin-Shahr area are infected 
by L. infantum. In spite of the persistence of 
visceral infection, more than 90% of L. infantum 
and L. donovani infection do not progress to 
clinically apparent diseases (21), but HIV-
positive or immunosuppressed status cases 
might be at the risk of acquiring clinical disease. 
Due to the observation of any clinical symptoms 
in seropositive subjects, this study found 
asymptomatic cases. Based on 
seroepidemiological surveys which were carried 
out in Iran, asymptomatic forms of VL caused 
by L. infantum were more than symptomatic 
ones (15), and considerable number of infected 
individuals only manifested a mild, 
oligosymptomatic disease that resolves without 
treatment (22). 
In this study, DAT was used for detection of L. 
infantum infection, according to previous study, 
the result of DAT is valid and reliable and showed 
with highly in specificity and sensitivity (23). 
The results of DAT showed in spite of 5% of 
cases in the studied areas had anti-Leishmania 
antibodies in titers of 1:400 (n = 2), 1:800  
(n = 4), 1:1600 (n = 3), none of them were DAT 
positive at titers 1:3200 and higher as cutoff 
values of DAT on human sera. The sensitivity 
and specificity of this method (DAT) vary in 
different studies between 90-100% and  
72-100%, respectively (9). 
 
Table 2. Results of DATs nine seropositive cases by age, gender and location 
Case No. Age (years) Gender Living place from Meshkin-Shahr area Antibody titer Sign and symptom 
1 42 Female South 1:1600 No 
2 23 Female Center 1:1600 No 
3 29 Female East 1:1600 No 
4 14 Female Center 1:800 No 
5 18 Female West 1:800 No 
6 32 Female Northwest 1:800 No 
7 27 Female Center 1:800 No 
8 23 Female Northwest 1:400 No 
9 21 Female Center 1:400 No 
DAT: Direct agglutination test 
 
 
43 
53 
30 
19 20 
8 7 
5 
3 
1 0 0 0 0 
0
10
20
30
40
50
60 Total
Seroprevalence survey of asymptomatic adults 
J Biostat Epidemiol. 2016; 2(3): 136-42.  
 
140 http://jbe.tums.ac.ir 
A serological study was conducted by 
Mohebali et al. (23). During 2002-2005 in some 
VL-endemic parts of the Iran, that results were 
as follows: In Ardabil Province, Meshkin-Shahr 
(3.6%), Germi (2.8%), Ardabil, Pars-Abad and 
Khalkhal (5.1%), in Chahar Mahal and Bakhtiari 
Province, Koohrang (2.3%), in Fars Province, 
Mamasani (1.9%), in Lorestan Province, 
Poshtkuh (1.3%), in Kohgiloyeh and Bouir 
ahmad Province, Yasuj (1.5%), in Khorasan 
Province, Bojnurd and Shirvan (0.46%). In Qom 
Province, Fakhar et al. (24) found 1.7% of 
seropositivity in 8 villages of Ghahan that three 
of seven seropositive cases had the previous 
history of VL and majority of the cases were 
among children among 7-10 years of age. In this 
study, all of the seropositive cases had not any 
previous history of VL. Mohebali et al. (25) 
found 3.4% sero-positivite subjects in Dashti 
and Dashtestan districts of Bushehr Province. 
Another serological survey was made by 
Mahmoudvand et al. (10) in Baft district, 
Kerman Province, in this study from 1476 
subjects, in only 23 cases (1.55%) observed anti-
Leishmania antibodies at titers of 1:800 and 
1:1600 and just in 14 cases (0.95%) observed 
anti-L. infantum antibodies at titers of ≥ 1:3200. 
According to the mentioned study, VL is 
endemic in the Northwest of Iran especially in 
Meshkin-Shahr District and according to the 
results of study L. infantum infection is 
relatively high in Meshkin-Shahr District. 
Furthermore, in our study, there was no 
significant difference between the rate of 
seropositivity and other sociodemographic 
characteristics (age groups, gender, location, 
occupation, history of VL, clinical symptoms, 
and contact with animals) (P > 0.05). In some of 
the previous studies conducted in Iran, there has 
been no relatively in consistency of the data 
between males and females (23, 24). Although 
any clinical disease by L. infantum has been 
reported in adults in Iran so far, there are so 
many reports in other endemic countries such as 
case reported in Turkey. A total of 14 cases  
(7 female, 7 male) diagnosed as VL in Adana 
and Anatolia, Turkey, and followed for 1 year. 
10 of the cases were immunocompetent and four 
were immunosuppressive. Clinical symptoms in 
these cases have been observed as followed: 
fever (57%), splenomegaly (79%) and 
hepatosplenomegaly (50%). The diagnosis of 
VL was made by the observation of amastigote 
in the smears of bone marrow aspiration (26). In 
another study in Turkey, data of 12 VL-patients 
in Hassan II, Fez Hospital was collected during 
to January 2009 to January 2014 (27). A  
31-year-old male patient, who was the first adult 
VL case from Zonguldak (a province located at 
western Black-Sea region of Turkey), was 
reported in another survey. He was hospitalized 
for 2 months with a history of fever, chills, 
sweating, and weight loss (28). In Iran, there are 
a few studies about adults suffering from  
L. infantum infection. 
Between 2004 and 2006, 802 apparently 
healthy subjects, in the Northwest and SouthEast 
of Fars province in Iran, were tested for anti-
Leishmania antibodies, by DAT, and for  
L. infantum kinetoplast DNA, in polymerase 
chain reaction (PCR)-based assays. Generally of 
the 426 cases from Northwestern Fars, by DAT, 
8 cases were found positive and by PCR 68. Of 
the 376 cases from South-Eastern Fars, by DAT 
5 cases were found positive and by PCR 32 (29). 
A total of 2003 healthy blood donors in ﬁve  
VL-endemic districts in Fars province, southern 
Iran, were collected and tested for antibodies 
against L. infantum by DAT. 28 blood donors 
(1.4%) were positive for Leishmania infection 
by DAT (30). 
After a month, the 9 seropositive cases were 
tested again but had not developed in clinical 
and none differences observed in the recent and 
previous test. 
Conclusion 
Our findings indicated that visceral L. infantum 
infection is still relative prevalent in Meshkin-
Shahr area in spite of control programs that have 
been implemented during last decades. Due to the 
importance of VL in immunocomromized patients, 
the surveillance system with DAT should be 
continued in the endemic foci of VL in Iran.  
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